PAR-23-059 - National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional)
is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
Notice of Special Interest (NOSI): Epidemiologic Studies to Assess the Impact of Incretin Mimetics on New and Recurrent Cancer Risk |
NOT-CA-24-037 |
NCI
|
Mar 7, 2024 |
May 9, 2026
|
K08, K22, R01, K99/R00, R21, P01 |
Notice of Special Interest (NOSI): Data Informed, Place-Based Community-Engaged Research to Advance Health Equity |
NOT-HL-23-110 |
NHLBI , NCI , NIDCR , NIEHS , NIMH , NIMHD , NINR , OBSSR , ODP , ORWH
|
Nov 28, 2023 |
Jan 8, 2027
|
R01, R34, R21, UG3/UH3, K01, R03, P01, P50, K08, K23 |
Notice of Special Interest in Research on Family Support and Rejection in the Health and Well-Being of SGM Populations |
NOT-OD-23-166 |
OD , NCI , NIA , NIAMS , NICHD , NIDDK , NIMH , NIMHD , OBSSR , ODP , ORWH , THRO
|
Aug 28, 2023 |
May 8, 2026
|
R21, R15, R01, R34, K25, K99/R00, K01, R03, P01, K08, K23 |
Notice of Special Interest (NOSI): Disparities Affecting Healthcare Utilization and Health Outcomes Among Childhood Cancer Survivors |
NOT-CA-22-029 |
NCI
|
Jan 7, 2022 |
Oct 9, 2024
|
R01, R21, P01, R03 |
Notice of Special Interest (NOSI): Research on Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment |
NOT-CA-22-014 |
NCI
|
Dec 8, 2021 |
Oct 9, 2024
|
R03, R01, R21, P01 |
Notice of Special Interest (NOSI): Accelerating Progress in Celiac Disease Research |
NOT-AI-22-004 |
NIAID , NIAMS , NCCIH , NCI
|
Nov 23, 2021 |
Jan 8, 2025
|
R03, R21, U01, U44, R01, R34, P01, R61/R33 |
Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity |
NOT-CA-22-001 |
NCI , NHLBI
|
Nov 4, 2021 |
Nov 6, 2024
|
R01, R03, R21, P01 |
Expired NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
Notice of Special Interest (NOSI): Addressing Cancer-Related Financial Hardship to Improve Patient Outcomes |
NOT-CA-22-045 |
NCI
|
Feb 3, 2022 |
Mar 1, 2024
|
P01, R21, R01, R03 |
Notice of Special Interest (NOSI): Clinical Characterization and Intervention Strategies for Cancer Therapy Induced Adverse Sequelae |
NOT-CA-22-005 |
NCI
|
Oct 28, 2021 |
May 8, 2023
|
P01 |
Notice of Special Interest (NOSI): Expanding Cancer Control Research in Persistent Poverty Areas |
NOT-CA-21-071 |
NCI
|
Apr 27, 2021 |
May 8, 2023
|
P01 |
Notice of Special Interest (NOSI): Understanding the effects of cancer and cancer treatment on aging trajectories and aging outcomes |
NOT-CA-21-031 |
NCI NIA
|
Jan 27, 2021 |
Jan 8, 2024
|
R21, R03, R01, U01, P01, K99/R00, K08, R43/R44, R41/R42, R13, R21/R33, K01, K23 |
Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions |
NOT-CA-20-044 |
NCI
|
Apr 9, 2020 |
May 8, 2023
|
R03, R21, R01, P01 |
Notice of Special Interest (NOSI): Research on Oral Anticancer Agents in the Contexts of Utilization, Adherence, and Health Care Delivery |
NOT-CA-20-026 |
NCI
|
Feb 21, 2020 |
May 8, 2023
|
R01, R21, R03, P01 |
|